NVO shares plunge 21% after Lilly's Zepbound and oral orforglipron beat its key GLP-1 drugs in head-to-head obesity and ...

A SAYS investigation found some medical practitioners are selling prescription weight-loss drugs like Ozempic without proper ...

Cost-effectiveness is highly price-sensitive; lower U.S. prices, particularly approaching European levels, shift semaglutide toward favorable value rather than a binary go/no-go determination. Patient ...

Some alleged medical practitioners are endangering lives by selling prescription drugs without proper screening and renting ...

Novo Nordisk announced Tuesday that it will cut U.S. list prices of Ozempic and Wegovy by up to 50% starting next year. The lower prices will take effect Jan. 1, 2027, the same time that reduced ...

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.

AUSTIN, TX / ACCESS Newswire / March 2, 2026 / In modern metabolic medicine, few treatments have reshaped care like GLP-1 ...